Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements
Launched by ACADEMY OF FINLAND · Feb 21, 2006
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
The aim of this study is to compare the cost-effectiveness of major joint replacement in patients with short and non-fixed (control group) waiting time (WT). After being placed on the waiting list, patients will be randomized into two groups through regular contact with the practice staff:
1. Patients with non-fixed waiting time (patient undergoes hospital's normal procedure from the date (s)he is added to the waiting list to the date of operation), and
2. patients with short waiting time (operated in maximum three months).
For ethical reasons, care will be taken to avoid any risk of ineq...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a need for a primary unilateral or bilateral THR (total hip replacement) or TKR (total knee replacement) due to osteoarthritis (OA) evaluated by the orthopaedic surgeon
- • aged 16 years or older
- • female or male
- • patient is placed on the waiting list in a research hospital
- • the patent is willing and mentally able to participate in the study.
- Exclusion Criteria:
- • Subjects with rheumatoid arthritis
- • Subjects with fractures
- • Subjects with haemophilia
- • Subjects with congenital deformities
- • Subjects with a need for re-arthroplasty
About Academy Of Finland
The Academy of Finland is a prominent governmental agency dedicated to advancing scientific research and innovation in Finland. It plays a crucial role in funding and supporting high-quality research across various disciplines, including health sciences, by promoting collaboration among researchers, institutions, and industry stakeholders. The Academy actively fosters the development of cutting-edge clinical trials that aim to enhance healthcare outcomes and address pressing medical challenges. Through its strategic initiatives and investment in research infrastructure, the Academy of Finland is committed to contributing to the global scientific community and improving public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Trial Officials
Marja L Blom, PhD
Study Director
Academy Of Finland/ Stakes/ National Research and Development Centre for Welfare and Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials